. a little under 60% of these encounters resulted in hospitalization and of these, about 13% required intensive care.
., an emerita professor in the department of food science & technology at uc davis.
.
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.